Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adhesion molecules.

Amy P N Skubitz1

  • 1Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Cancer Treatment and Research
|January 5, 2002
PubMed
Summary

Understanding how serous ovarian cancer cells invade is key. Adhesion molecules like CD44 and integrins are crucial for cancer cell spread, and targeting them may prevent metastasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein Enrichment from Ascites Fluid Using Nanotrap Hydrogel Particle Technology.

Journal of proteome research·2026
Same author

Repurposing the liquid-based Pap test for the detection of ovarian cancer protein biomarkers.

Clinical proteomics·2026
Same author

A Peptide Derived from Nectin-4 Increases Cisplatin Cytotoxicity in Cell Lines and Cells from Ovarian Cancer Patients' Ascites.

Cancers·2025
Same author

Metabolomics of Papanicolaou Tests for the Discovery of Ovarian Cancer Biomarkers.

Metabolites·2024
Same author

A novel clinical metaproteomics workflow enables bioinformatic analysis of host-microbe dynamics in disease.

mSphere·2024
Same author

Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay.

Clinical proteomics·2024

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • The precise mechanisms of serous ovarian cancer cell invasion and detachment from the ovary remain unclear.
  • This process involves complex molecular interactions including cell surface receptors, basement membrane components, and intercellular adhesion molecules.
  • Ovarian cancer progression may involve tumor cells altering their basement membrane via proteolytic enzymes or by modifying extracellular matrix (ECM) molecule synthesis.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying serous ovarian cancer cell invasion and metastasis.
  • To investigate the role of adhesion molecules and their ligands in ovarian cancer progression.
  • To identify potential therapeutic targets for inhibiting ovarian cancer cell dissemination.

Main Methods:

  • Review of existing literature on ovarian cancer cell invasion and metastasis.
  • Analysis of the roles of specific adhesion molecules (e.g., CD44, integrins, E-cadherin) in cancer cell behavior.
  • Exploration of cell-matrix and cell-cell interactions in the context of ovarian cancer.

Main Results:

  • Adhesion molecules, including CD44 and the beta 1 integrin subunit, are fundamental to ovarian carcinoma cell adhesion and migration to mesothelial cells.
  • Ovarian cancer cell invasion involves migration through mesothelial layers, penetration of the basement membrane, and subsequent tissue invasion.
  • Altered cellular responses to ECM molecules, potentially due to changes in adhesion molecules/receptors, may contribute to the aggressive behavior of malignant ovarian cancer cells.

Conclusions:

  • Further research is required to fully understand the complex interplay of adhesion molecules and their ligands in ovarian cancer progression.
  • Identifying these molecular interactions is crucial for developing targeted therapies to inhibit ovarian cancer cell dissemination.
  • Targeting specific adhesion molecule-ligand interactions could prevent the spread of ovarian carcinoma cells in vivo.

Related Experiment Videos